On May 27, BeiGene declined 3.07% in regular trading, trading at HK$182.5/share, with trading volume of approximately HK$146 million.

Within the Biotechnology sector where BeiGene belongs, among individual stocks, Innovent Bio down 0.38%, Akeso up 1.43%, PegBio Co-B down 26.3%, 3SBio up 0.27%, Transthera-B up 4.63%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)